SYRE vs MSFT: Which Stock is Better?
Side-by-side comparison of Spyre Therapeutics Inc. and Microsoft Corporation in 2026
SYRE
Spyre Therapeutics Inc.
—
MSFT
Microsoft Corporation
$390.49
Key Metrics Comparison
| Metric | SYRE | MSFT | Winner |
|---|---|---|---|
| Market Cap | $7.60B | $3.71T | MSFT |
| P/E Ratio | N/A | 38.61 | MSFT |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze SYRE
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRE or MSFT a better investment?
Comparing SYRE and MSFT: Spyre Therapeutics Inc. has a market cap of $7.60B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRE and MSFT?
SYRE (Spyre Therapeutics Inc.) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRE or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRE or MSFT?
Both SYRE and MSFT show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: SYRE or MSFT?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: SYRE or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $7.60B for SYRE.
Should I buy SYRE or MSFT in 2026?
Both SYRE and MSFT have investment merit. SYRE trades at $N/A while MSFT trades at $390.49. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRE and MSFT stock?
Key differences: Market Cap ($7.60B vs $3.71T), P/E Ratio (N/A vs 38.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy SYRE or MSFT in 2026?
The choice between SYRE and MSFT depends on your investment goals. MSFT shows higher revenue growth (0.0%). MSFT has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between SYRE and MSFT?
SYRE (Spyre Therapeutics Inc.) has a market cap of $7.60B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.